130 related articles for article (PubMed ID: 1381438)
1. Characterization of HIV isolates arising after prolonged zidovudine therapy.
Mayers DL; McCutchan FE; Sanders-Buell EE; Merritt LI; Dilworth S; Fowler AK; Marks CA; Ruiz NM; Richman DD; Roberts CR
J Acquir Immune Defic Syndr (1988); 1992; 5(8):749-59. PubMed ID: 1381438
[TBL] [Abstract][Full Text] [Related]
2. Zidovudine resistance mutations and human immunodeficiency virus type 1 DNA burden: longitudinal evaluation of six patients under treatment.
Zazzi M; Catucci M; De Milito A; Romano L; Venturi G; Almi P; Gonnelli A; Rubino M; Valensin PE
Infection; 1996; 24(6):419-25. PubMed ID: 9007588
[TBL] [Abstract][Full Text] [Related]
3. [Mutations of HIV-1 RT gene isolated from patients treated with AZT].
Kondo M; Saito T; Ito A; Oka S; Takata N; Imai M
Kansenshogaku Zasshi; 1993 Mar; 67(3):185-9. PubMed ID: 7683706
[TBL] [Abstract][Full Text] [Related]
4. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
Larder BA; Kemp SD
Science; 1989 Dec; 246(4934):1155-8. PubMed ID: 2479983
[TBL] [Abstract][Full Text] [Related]
5. Additional mutations detected in sequential HIV-1 isolates from ZDV-treated patients.
Magierowska-Jung M; Agut H; Katlama C; Autran B; Huraux JM
J Med Virol; 1997 Jan; 51(1):48-55. PubMed ID: 8986949
[TBL] [Abstract][Full Text] [Related]
6. Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolates.
Shafer RW; Kozal MJ; Katzenstein DA; Lipil WH; Johnstone IF; Merigan TC
J Virol Methods; 1993 Mar; 41(3):297-310. PubMed ID: 8097199
[TBL] [Abstract][Full Text] [Related]
7. Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosine.
Masquelier B; Pellegrin I; Ruffault A; Ragnaud JM; Morlat P; Michelet C; Doignon F; Biteau N; Fleury HJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):330-4. PubMed ID: 7533640
[TBL] [Abstract][Full Text] [Related]
8. Detection of human immunodeficiency virus type 1 clinical isolates with reduced sensitivity to zidovudine and dideoxyinosine by RNA.RNA hybridization.
Japour AJ; Chatis PA; Eigenrauch HA; Crumpacker CS
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3092-6. PubMed ID: 1707532
[TBL] [Abstract][Full Text] [Related]
9. Reverse transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS.
Gurusinghe AD; Land SA; Birch C; McGavin C; Hooker DJ; Tachedjian G; Doherty R; Deacon NJ
J Med Virol; 1995 Jul; 46(3):238-43. PubMed ID: 7561796
[TBL] [Abstract][Full Text] [Related]
10. Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment.
Di Stefano M; Sabri F; Leitner T; Svennerholm B; Hagberg L; Norkrans G; Chiodi F
J Clin Microbiol; 1995 Feb; 33(2):352-5. PubMed ID: 7536214
[TBL] [Abstract][Full Text] [Related]
11. A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215.
Rusconi S; La Seta Catamancio S; Sheridan F; Parker D
J Clin Virol; 2000 Dec; 19(3):135-42. PubMed ID: 11090748
[TBL] [Abstract][Full Text] [Related]
12. An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine.
Hooker DJ; Tachedjian G; Solomon AE; Gurusinghe AD; Land S; Birch C; Anderson JL; Roy BM; Arnold E; Deacon NJ
J Virol; 1996 Nov; 70(11):8010-8. PubMed ID: 8892925
[TBL] [Abstract][Full Text] [Related]
13. [Reverse transcriptase gene analysis of HIV-1 mutants cultured in the presence of AZT].
Kondo M; Saito T; Ito A; Oka S; Hamamoto K; Imai M
Kansenshogaku Zasshi; 1993 Oct; 67(10):992-7. PubMed ID: 7504715
[TBL] [Abstract][Full Text] [Related]
14. Predominance of codon 215 mutation in reverse transcriptase-coding region of 3'-azido-3'-deoxythymidine (AZT)-resistant HIV-1 isolates after long-term AZT therapy.
Kondo M
Kansenshogaku Zasshi; 1995 Nov; 69(11):1278-85. PubMed ID: 8708409
[TBL] [Abstract][Full Text] [Related]
15. Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction.
Richman DD; Guatelli JC; Grimes J; Tsiatis A; Gingeras T
J Infect Dis; 1991 Dec; 164(6):1075-81. PubMed ID: 1720152
[TBL] [Abstract][Full Text] [Related]
16. Selective vertical transmission of HIV-1 antiretroviral resistance mutations.
Colgrove RC; Pitt J; Chung PH; Welles SL; Japour AJ
AIDS; 1998 Dec; 12(17):2281-8. PubMed ID: 9863870
[TBL] [Abstract][Full Text] [Related]
17. Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine.
Ntemgwa M; Wainberg MA; Oliveira M; Moisi D; Lalonde R; Micheli V; Brenner BG
Antimicrob Agents Chemother; 2007 Nov; 51(11):3861-9. PubMed ID: 17724152
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of HIV-1 isolates to zidovudine: correlation between widely applicable culture test and PCR analysis.
Jung M; Agut H; Candotti D; Ingrand D; Katlama C; Huraux JM
J Acquir Immune Defic Syndr (1988); 1992; 5(4):359-64. PubMed ID: 1372352
[TBL] [Abstract][Full Text] [Related]
19. Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro.
Muckenthaler M; Gunkel N; Levantis P; Broadhurst K; Goh B; Colvin B; Forster G; Jackson GG; Oxford JS
J Med Virol; 1992 Feb; 36(2):79-83. PubMed ID: 1374791
[TBL] [Abstract][Full Text] [Related]
20. Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors.
Venturi G; Romano L; Catucci M; Riccio ML; De Milito A; Gonnelli A; Rubino M; Valensin PE; Zazzi M
Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):274-82. PubMed ID: 10385016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
